SAFTY
Clinical trials for SAFTY explained in plain language.
Never miss a new study
Get alerted when new SAFTY trials appear
Sign up with your email to follow new studies for SAFTY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Injection's effect on statin metabolism under the microscope
Knowledge-focused CompletedThis study investigates whether a new injectable drug called Y-3 changes how the body processes rosuvastatin, a widely used cholesterol-lowering medication. Twenty healthy adults aged 18 to 50 will take rosuvastatin alone and then together with Y-3 to measure any drug-drug intera…
Matched conditions: SAFTY
Phase: PHASE1 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
New injection Y-3 put to the test: will it clash with common drugs?
Knowledge-focused CompletedThis completed Phase 1 trial in 24 healthy adults checked whether an experimental injection called Y-3 changes how the body handles three common drugs: repaglinide (for diabetes), warfarin (a blood thinner), and omeprazole (for heartburn). Participants took these drugs alone and …
Matched conditions: SAFTY
Phase: PHASE1 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC